Schonfeld Strategic Advisors’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
VCM
QF
PM
GI
Schonfeld Strategic Advisors's ATEX Position: Q1 2026 in Review
Schonfeld Strategic Advisors reduced its Anterix (ATEX) stake by 53% in Q1 2026, selling an estimated $831K and leaving 23,211 shares worth $886K. The position accounts for 0.01% of the portfolio, ranked #1154.
Schonfeld Strategic Advisors first reported a position in ATEX in Q2 2020 and has held it in 13 quarters since. The position peaked at $7.96M in Q1 2021. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.
- Schonfeld Strategic Advisors held 23,211 shares of Anterix worth $886K as of Q1 2026.
- Schonfeld Strategic Advisors sold 26,251 Anterix shares in Q1 2026, an estimated $831K.
- Anterix made up 0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #1154 holding.
- Schonfeld Strategic Advisors first reported a position in Anterix in Q2 2020 and has held it in 13 quarters since.
- Schonfeld Strategic Advisors's Anterix position peaked at $7.96M in Q1 2021.
- 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.